7-10-2-6　ⓔ文献

  1. World Health Organization: WHO Coronavirus (COVID–19) Dashboard. https://covid19.who.int　2021年9月14日

  2. Lu R, Zhao X, et al: Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020; 395: 565–574.

  3. Yan R, Zhang Y, et al: Structural basis for the recognition of SARS–CoV–2 by full–length human ACE2. Science, 2020; 367: 1444–1448.

  4. World Health Organization: Tracking SARS–CoV–2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/(2021年9月14日)

  5. Nelemans T, Kikkert. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses, 2019; 11: 961.

  6. Cheung CY, Poon LLM, et al: Cytokine responses in severe acute respiratory syndrome coronavirus–induced macrophages in vitro: possible relevance to pathogenesis. J Virol, 2005; 79: 7819–7826.

  7. Guan W, Ni ZY, et al: Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med, 2020; 382: 1708–1720.

  8. Goyal P, Choi JJ, et al: Clinical characteristics of covid–19 in New York city. N Engl J Med, 2020; 382: 2372–2374.

  9. Blomberg B, Mohn KG, et al: Long COVID in a prospective cohort of home-isolated patients. Nature medicine, 2021; 27: 1607–1613.